Author:
Zhang Yan,Zhang Xue-Ying,Shi Shan-Rui,Ma Chao-Nan,Lin Yun-Peng,Song Wen-Gang,Guo Shou-Dong
Abstract
Inflammation and dyslipidemia are critical inducing factors of atherosclerosis. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors and control the expression of multiple genes that are involved in lipid metabolism and inflammatory responses. However, synthesized PPAR agonists exhibit contrary therapeutic effects and various side effects in atherosclerosis therapy. Natural products are structural diversity and have a good safety. Recent studies find that natural herbs and compounds exhibit attractive therapeutic effects on atherosclerosis by alleviating hyperlipidemia and inflammation through modulation of PPARs. Importantly, the preparation of natural products generally causes significantly lower environmental pollution compared to that of synthesized chemical compounds. Therefore, it is interesting to discover novel PPAR modulator and develop alternative strategies for atherosclerosis therapy based on natural herbs and compounds. This article reviews recent findings, mainly from the year of 2020 to present, about the roles of natural herbs and compounds in regulation of PPARs and their therapeutic effects on atherosclerosis. This article provides alternative strategies and theoretical basis for atherosclerosis therapy using natural herbs and compounds by targeting PPARs, and offers valuable information for researchers that are interested in developing novel PPAR modulators.
Reference224 articles.
1. Association between medication adherence and cardiovascular outcomes among acute coronary syndrome patients;Chinwong;Res Social Adm Pharm,2021
2. Yang-Xin-Shu-Mai granule alleviates atherosclerosis by regulating macrophage polarization via the TLR9/MyD88/NF-κB signaling pathway;Huang;J Ethnopharmacol,2024
3. Therapeutic strategy for atherosclerosis based on bone-vascular axis hypothesis;Kim;Pharmacol Ther,2020
4. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study;Song;Lancet Glob Health,2020
5. Atherosclerosis, cardiovascular disease, and COVID-19: a narrative review;Vilaplana-Carnerero;Biomedicines,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献